149 related articles for article (PubMed ID: 15213171)
1. Structural relationships and cellular tropism of staphylococcal superantigen-like proteins.
Al-Shangiti AM; Naylor CE; Nair SP; Briggs DC; Henderson B; Chain BM
Infect Immun; 2004 Jul; 72(7):4261-70. PubMed ID: 15213171
[TBL] [Abstract][Full Text] [Related]
2. The interaction between staphylococcal superantigen-like proteins and human dendritic cells.
Al-Shangiti AM; Nair SP; Chain BM
Clin Exp Immunol; 2005 Jun; 140(3):461-9. PubMed ID: 15932507
[TBL] [Abstract][Full Text] [Related]
3. Generation of a Monoclonal Antibody Against Staphylococcal Superantigen-Like Protein 5 (SSL5) That Discriminates SSL5 from Other SSL Proteins.
Oku T; Soma H; Kurisaka C; Tsuji T
Monoclon Antib Immunodiagn Immunother; 2018 Nov; 37(5):212-217. PubMed ID: 30362929
[TBL] [Abstract][Full Text] [Related]
4. Identification of Set11 from Staphylococcus aureus Mu50 strain as a ortholog of SSL7 via bioinformatic analysis and determination of its possible targets from human serum using CNBr-pull down assays.
Li Y; Chen X; Jia N; Zhang X; Zang J
Biotechnol Lett; 2017 Sep; 39(9):1413-1423. PubMed ID: 28653102
[TBL] [Abstract][Full Text] [Related]
5. Structural basis for evasion of IgA immunity by Staphylococcus aureus revealed in the complex of SSL7 with Fc of human IgA1.
Ramsland PA; Willoughby N; Trist HM; Farrugia W; Hogarth PM; Fraser JD; Wines BD
Proc Natl Acad Sci U S A; 2007 Sep; 104(38):15051-6. PubMed ID: 17848512
[TBL] [Abstract][Full Text] [Related]
6. The structure of the C5a receptor-blocking domain of chemotaxis inhibitory protein of Staphylococcus aureus is related to a group of immune evasive molecules.
Haas PJ; de Haas CJ; Poppelier MJ; van Kessel KP; van Strijp JA; Dijkstra K; Scheek RM; Fan H; Kruijtzer JA; Liskamp RM; Kemmink J
J Mol Biol; 2005 Nov; 353(4):859-72. PubMed ID: 16213522
[TBL] [Abstract][Full Text] [Related]
7. Staphylococcal superantigen-like protein 10 (SSL10) binds to human immunoglobulin G (IgG) and inhibits complement activation via the classical pathway.
Itoh S; Hamada E; Kamoshida G; Yokoyama R; Takii T; Onozaki K; Tsuji T
Mol Immunol; 2010 Jan; 47(4):932-8. PubMed ID: 19913916
[TBL] [Abstract][Full Text] [Related]
8. Multiple Domains of Staphylococcal Superantigen-like Protein 11 (SSL11) Contribute to Neutrophil Inhibition.
Yang C; Barbieri JT; Dahms NM; Chen C
Biochemistry; 2022 Apr; 61(7):616-624. PubMed ID: 35285627
[No Abstract] [Full Text] [Related]
9. Crystal structures of the staphylococcal toxin SSL5 in complex with sialyl Lewis X reveal a conserved binding site that shares common features with viral and bacterial sialic acid binding proteins.
Baker HM; Basu I; Chung MC; Caradoc-Davies T; Fraser JD; Baker EN
J Mol Biol; 2007 Dec; 374(5):1298-308. PubMed ID: 17996251
[TBL] [Abstract][Full Text] [Related]
10. Staphylococcal superantigen-like protein 10 binds to phosphatidylserine and apoptotic cells.
Itoh S; Yokoyama R; Murase C; Takii T; Tsuji T; Onozaki K
Microbiol Immunol; 2012 Jun; 56(6):363-71. PubMed ID: 22486378
[TBL] [Abstract][Full Text] [Related]
11. Staphylococcal superantigen-like protein 10 (SSL10) inhibits blood coagulation by binding to prothrombin and factor Xa via their γ-carboxyglutamic acid (Gla) domain.
Itoh S; Yokoyama R; Kamoshida G; Fujiwara T; Okada H; Takii T; Tsuji T; Fujii S; Hashizume H; Onozaki K
J Biol Chem; 2013 Jul; 288(30):21569-80. PubMed ID: 23754290
[TBL] [Abstract][Full Text] [Related]
12. The staphylococcal superantigen-like protein 7 binds IgA and complement C5 and inhibits IgA-Fc alpha RI binding and serum killing of bacteria.
Langley R; Wines B; Willoughby N; Basu I; Proft T; Fraser JD
J Immunol; 2005 Mar; 174(5):2926-33. PubMed ID: 15728504
[TBL] [Abstract][Full Text] [Related]
13. Specificity of staphylococcal superantigen-like protein 10 toward the human IgG1 Fc domain.
Patel D; Wines BD; Langley RJ; Fraser JD
J Immunol; 2010 Jun; 184(11):6283-92. PubMed ID: 20427768
[TBL] [Abstract][Full Text] [Related]
14. Identification of human plasma C1 inhibitor as a target protein for staphylococcal superantigen-like protein 5 (SSL5).
Oku T; Kurisaka C; Ando Y; Tsuji T
Biochem Biophys Res Commun; 2019 Jan; 508(4):1162-1167. PubMed ID: 30554660
[TBL] [Abstract][Full Text] [Related]
15. The bacterial superantigen and superantigen-like proteins.
Fraser JD; Proft T
Immunol Rev; 2008 Oct; 225():226-43. PubMed ID: 18837785
[TBL] [Abstract][Full Text] [Related]
16. Identification of matrix metalloproteinase 9-interacting sequences in staphylococcal superantigen-like protein 5.
Kohno K; Itoh S; Hanai A; Takii T; Fujiwara T; Onozaki K; Tsuji T; Hida S
Biochem Biophys Res Commun; 2018 Mar; 497(2):713-718. PubMed ID: 29462623
[TBL] [Abstract][Full Text] [Related]
17. Staphylococcal superantigen-like protein 8 (SSL8) binds to tenascin C and inhibits tenascin C-fibronectin interaction and cell motility of keratinocytes.
Itoh S; Yamaoka N; Kamoshida G; Takii T; Tsuji T; Hayashi H; Onozaki K
Biochem Biophys Res Commun; 2013 Mar; 433(1):127-32. PubMed ID: 23485472
[TBL] [Abstract][Full Text] [Related]
18. The crystal structure of staphylococcal superantigen-like protein 11 in complex with sialyl Lewis X reveals the mechanism for cell binding and immune inhibition.
Chung MC; Wines BD; Baker H; Langley RJ; Baker EN; Fraser JD
Mol Microbiol; 2007 Dec; 66(6):1342-55. PubMed ID: 18045383
[TBL] [Abstract][Full Text] [Related]
19. Conservation and variation in superantigen structure and activity highlighted by the three-dimensional structures of two new superantigens from Streptococcus pyogenes.
Arcus VL; Proft T; Sigrell JA; Baker HM; Fraser JD; Baker EN
J Mol Biol; 2000 May; 299(1):157-68. PubMed ID: 10860729
[TBL] [Abstract][Full Text] [Related]
20. Staphylococcal superantigen super-domains in immune evasion.
Langley R; Patel D; Jackson N; Clow F; Fraser JD
Crit Rev Immunol; 2010; 30(2):149-65. PubMed ID: 20370627
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
